3Paemans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small cell lung cancer: uni-and multivariate analysis including RECPAM in 1052 patients. J Clin Oncol 1995;13:1221-1230.
4Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Reseach. Br J Cancer 1990;61:597-604.
5Sagman U, Feld R, Evans WK, et al. The prognostic significance of pretrement serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oneol 1991;9:954-961.
6Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer: multivariate moded based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986;46:4189-4194.
7Brambilla C, Brambilla E. Lung Tumors, fundamental biology and clinical management. New York: Marcel Dekkerlnc,1999 : 157-171, 173-190, 211-225, 269-277, 347-364,365-382, 399-422, 423-433, 435-452, 583-593.
8Ogawa J, Tsurumi T, Inoue H, et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990;65:1391-1395.
9Asiner J, Arriagada R, Green MR, et al. Comprehensive textbook of thoracic oneology. Baltimore: Williams & Wilkins, 1996: 25-35,276-292,319-335.
10Palomares MR, 8ayre JW, Shekar KC, et al. Gender influence on weight-loss pattern and survival of non-small cell lung carcinoma patinents. Cancer 1996;78:9.119-2126.
10Paschoalini MDAS, Vargas FS, Marchi E, et al. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest, 2005, 128 (2): 684-689.
